- Cannabix Technologies (CSE:BLO) has begun the commercial rollout for its Marijuana Breath Test, including deliveries to customers across numerous industries
- Cannabix develops marijuana and alcohol breath technologies for workplaces, law enforcement and other safety-sensitive settings
- The cannabis stock has added 11.11 per cent year-over-year but remains down by 58.62 per cent since 2021
Cannabix Technologies (CSE:BLO) has begun the commercial rollout for its Marijuana Breath Test, including deliveries to customers across numerous industries.
The Marijuana Breath Test enables the immediate, non-invasive detection of delta-9 THC, the primary psychoactive compound in cannabis, within 4 hours of consumption at levels above 5 pg/L, closely aligning it with the period of peak impartment. A peer-reviewed study in the Journal of Analytical Toxicology published in March 2026 validated these specifications.
The device addresses an unmet need for law enforcement agencies and other safety-sensitive industries, which have traditionally relied on urine, saliva or hair-based tests that take anywhere from hours to weeks to generate results.
The rollout and planned scale-up is supported by a partnership with Omega Laboratories, a top forensic drug testing company that developed the testing method utilized by the device.
According to Monday’s news release, leadership intends to build a recurring revenue model around its technology, with Breath Collection Units serving as required hardware and Breath Cartridges required for every test performed.
About Cannabix Technologies
Cannabix Technologies develops marijuana and alcohol breath technologies for workplaces, law enforcement and other safety-sensitive settings.
Cannabix stock (CSE:BLO) is up by 17.65 per cent on the news trading at C$0.60 as of 11:32 am ET. The stock has added 11.11 per cent year-over-year but remains down by 58.62 per cent since 2021.
Join the discussion: Find out what investors are saying about this cannabis breathalyzer stock on the Cannabix Technologies Inc. Bullboard and make sure to explore the rest of Stockhouse’s stock forums and message boards.
Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein.
For full disclaimer information, please click here.